Cogent Biosciences, Inc. Basic Shares Outstanding (Weighted Average)
Cogent Biosciences, Inc. (COGT) reported Basic Shares Outstanding (Weighted Average) of 171.01 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 171.01M shares, a 49.39% increase year-over-year.
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 162.19M shares, a 43.15% increase year-over-year.
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 150.01M shares, a 35.00% increase year-over-year.
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 137.55M shares, a 24.86% increase year-over-year.
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 128.90M shares, a 24.11% increase from fiscal 2024.
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 103.86M shares, a 30.38% increase from fiscal 2023.
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 79.66M shares, a 35.61% increase from fiscal 2022.
- Cogent Biosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 58.74M shares, a 51.66% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 171.01M shares 10-Q · filed 2026-08-10 | 166.62M shares 10-Q · filed 2026-08-10 | 161.07M shares derived: average of 3 quarters · filed 2026-08-10 | 155.19M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 162.19M shares 10-Q · filed 2026-05-05 | 156.10M shares derived: average of 2 quarters · filed 2026-05-05 | 149.92M shares derived: average of 3 quarters · filed 2026-05-05 | 141.05M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | 150.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | 143.78M shares derived: average of 2 quarters · filed 2026-02-17 | 134.01M shares derived: average of 3 quarters · filed 2026-08-10 | 128.90M shares 10-K · filed 2026-02-17 |
| 2025-09-30 | 137.55M shares 10-Q · filed 2025-11-07 | 126.01M shares derived: average of 2 quarters · filed 2026-08-10 | 121.86M shares 10-Q · filed 2025-11-07 | 119.11M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | 114.47M shares 10-Q · filed 2026-08-10 | 114.46M shares 10-Q · filed 2026-08-10 | 112.96M shares derived: average of 3 quarters · filed 2026-08-10 | 112.26M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | 113.31M shares 10-Q · filed 2026-05-05 | 112.21M shares derived: average of 2 quarters · filed 2026-05-05 | 111.53M shares derived: average of 3 quarters · filed 2026-05-05 | 108.46M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | 111.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | 110.64M shares derived: average of 2 quarters · filed 2026-02-17 | 106.84M shares derived: average of 3 quarters · filed 2026-02-17 | 103.86M shares 10-K · filed 2026-02-17 |
| 2024-09-30 | 110.17M shares 10-Q · filed 2025-11-07 | 104.70M shares derived: average of 2 quarters · filed 2025-11-07 | 101.44M shares 10-Q · filed 2025-11-07 | 97.75M shares derived: average of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | 99.24M shares 10-Q · filed 2025-08-05 | 97.02M shares 10-Q · filed 2025-08-05 | 93.62M shares derived: average of 3 quarters · filed 2026-02-17 | 91.75M shares derived: average of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | 94.80M shares 10-Q · filed 2025-05-06 | 90.81M shares derived: average of 2 quarters · filed 2026-02-17 | 89.26M shares derived: average of 3 quarters · filed 2026-02-17 | 85.63M shares derived: average of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | 86.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | 86.49M shares derived: average of 2 quarters · filed 2026-02-17 | 82.58M shares derived: average of 3 quarters · filed 2026-02-17 | 79.66M shares 10-K · filed 2026-02-17 |
| 2023-09-30 | 86.17M shares 10-Q · filed 2024-11-12 | 80.46M shares derived: average of 2 quarters · filed 2024-11-12 | 77.27M shares 10-Q · filed 2024-11-12 | 75.57M shares derived: average of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | 74.75M shares 10-Q · filed 2024-08-06 | 72.76M shares 10-Q · filed 2024-08-06 | 72.04M shares derived: average of 3 quarters · filed 2025-02-25 | 71.42M shares derived: average of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | 70.73M shares 10-Q · filed 2024-05-07 | 70.68M shares derived: average of 2 quarters · filed 2025-02-25 | 70.31M shares derived: average of 3 quarters · filed 2025-02-25 | 65.08M shares derived: average of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | 70.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 70.10M shares derived: average of 2 quarters · filed 2025-02-25 | 63.19M shares derived: average of 3 quarters · filed 2025-02-25 | 58.74M shares 10-K · filed 2025-02-25 |
| 2022-09-30 | 69.58M shares 10-Q · filed 2023-11-07 | 59.48M shares derived: average of 2 quarters · filed 2023-11-07 | 54.78M shares 10-Q · filed 2023-11-07 | 51.44M shares derived: average of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | 49.39M shares 10-Q · filed 2023-08-08 | 47.26M shares 10-Q · filed 2023-08-08 | 45.40M shares derived: average of 3 quarters · filed 2024-02-26 | 44.01M shares derived: average of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | 45.11M shares 10-Q · filed 2023-05-09 | 43.40M shares derived: average of 2 quarters · filed 2024-02-26 | 42.22M shares derived: average of 3 quarters · filed 2024-02-26 | 41.27M shares derived: average of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | 41.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | 40.77M shares derived: average of 2 quarters · filed 2024-02-26 | 40.00M shares derived: average of 3 quarters · filed 2024-02-26 | 38.73M shares 10-K · filed 2024-02-26 |
| 2021-09-30 | 39.85M shares 10-Q · filed 2022-11-14 | 39.15M shares derived: average of 2 quarters · filed 2022-11-14 | 37.74M shares 10-Q · filed 2022-11-14 | |
| 2021-06-30 | 38.44M shares 10-Q · filed 2022-08-09 | 36.67M shares 10-Q · filed 2022-08-09 | ||
| 2019-12-31 | 30.66B shares 10-K · filed 2020-03-26 | 30.66B shares derived: average of 2 quarters · filed 2020-03-26 | 30.61B shares derived: average of 3 quarters · filed 2020-03-26 | 30.48B shares derived: average of 4 quarters · filed 2020-03-26 |
| 2019-09-30 | 30.66B shares 10-K · filed 2020-03-26 | 30.58B shares derived: average of 2 quarters · filed 2020-03-26 | 30.42B shares derived: average of 3 quarters · filed 2020-03-26 | 30.32B shares derived: average of 4 quarters · filed 2020-03-26 |
| 2019-06-30 | 30.51B shares 10-K · filed 2020-03-26 | 30.29B shares derived: average of 2 quarters · filed 2020-03-26 | 30.20B shares derived: average of 3 quarters · filed 2020-03-26 | 30.12B shares derived: average of 4 quarters · filed 2020-03-26 |
| 2019-03-31 | 30.08B shares 10-K · filed 2020-03-26 | 30.05B shares derived: average of 2 quarters · filed 2020-03-26 | 29.99B shares derived: average of 3 quarters · filed 2020-03-26 | 29.78B shares derived: average of 4 quarters · filed 2020-03-26 |
| 2018-12-31 | 30.02B shares 10-K · filed 2020-03-26 | 29.95B shares derived: average of 2 quarters · filed 2020-03-26 | 29.68B shares derived: average of 3 quarters · filed 2020-03-26 | 24.81B shares derived: average of 4 quarters · filed 2020-03-26 |
| 2018-09-30 | 29.88B shares 10-K · filed 2020-03-26 | 29.52B shares derived: average of 2 quarters · filed 2020-03-26 | 23.08B shares derived: average of 3 quarters · filed 2020-03-26 | |
| 2018-06-30 | 29.16B shares 10-K · filed 2020-03-26 | 19.68B shares derived: average of 2 quarters · filed 2020-03-26 | ||
| 2018-03-31 | 10.20B shares 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |